ZoomMed inc.

ZoomMed inc.

December 14, 2005 23:59 ET

ZoomMed announces the filing of a final prospectus

MONTREAL, Dec. 14 - ZoomMed Inc. ("ZoomMed") (TSX Venture
Exchange: ZMD) announces that it has received a receipt for its final
prospectus dated December 12, 2005 relating to the previously announced
offering of a minimum of 3,750,000 common shares of ZoomMed and a maximum of
12,500,000 common shares of ZoomMed, at a price of $0.20 per common share, for
minimum gross proceeds of $750,000 and maximum gross proceeds of $2,500,000
(the "Offering"). The price of the Offering was determined jointly by ZoomMed
and Versant Partners Inc., which has agreed to act as agent for the Offering
pursuant to the terms of an agency agreement dated as of December 1st, 2005.

Furthermore, as previously announced, ZoomMed has obtained an advance
income tax ruling from the Ministère du Revenu du Québec in order to confirm
that the Common Shares of ZoomMed to be issued pursuant to this Offering will
be eligible shares, upon issuance, for inclusion in an SME Growth Stock Plan.

The first closing of the Offering is expected to take place on or about
December 23rd 2005.

ZoomMed is presently developing a new electronic tool "ZRx Prescriber",
intended to change the way drugs are prescribed and dispensed throughout
Canada. This handheld prescribing system device, equipped with tools such as a
therapeutic advisor as well as a medication interaction manager, will enable
doctors to fill prescriptions and to electronically transmit them in a fast
and secure mode. This user friendly Web product, designed for doctors, will
use the latest "Pocket PC" technologies.

The TSX Venture Exchange has neither approved nor accepts any
responsibility with respect to the veracity or exactitude of this press

Contact Information